India's Resilience Amid Trump's Tariff Turmoil: A Focus on Generic Drugs
Published on: April 3, 2026, 5:45 p.m. | Source: Devdiscourse
India remains insulated from US's new 100% tariffs on patented drugs due to its strong foothold in exporting low-cost generics to America. This strategic market position keeps the nation shielded from immediate impacts. Future uncertainties loom for Indian innovators as global trade dynamics continue to evolve.
